EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring the crosstalk between the FGF/FGFR pathway and tumor microenvironment in clear cell renal cell carcinoma

Takafumi Narisawa iD, Sei Naito, Yoshihide Mitsuda, Rintaro Ohe iD, Hidenori Sato, Chizuru Kobayashi iD, Yuki Miyano, Hiromi Ito, Mitsuru Futakuchi iD, Norihiko Tsuchiya

PLOS One · 2026

DOI: 10.1371/journal.pone.0339888 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Takafumi Narisawa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Faculty of Medicine, Yamagata University, Yamagata, Japan. Hauptthemen laut MEDLINE: Tumor Microenvironment, Carcinoma, Renal Cell, Kidney Neoplasms, Receptors, Fibroblast Growth Factor. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Eisai Co., Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In the phase 3 CLEAR study, lenvatinib plus pembrolizumab showed improved efficacy versus sunitinib for patients with clear cell renal cell carcinoma (ccRCC). Previous preclinical studies demonstrated that lenvatinib attenuated tumor-associated macrophage (TAM) infiltration into tumor tissues by inhibiting fibroblast growth factor receptor (FGFR). However, the role of the FGFR pathway in ccRCC remains underexplored. This study aims to evaluate FGFR1–4 expression in ccRCC and investigate its relationship with the tumor microenvironment, particularly TAM.

Methods

We primarily analyzed FGFR1–4 expression and CD163 positive cell count as estimation of TAM infiltration in 57 ccRCC specimens from patients undergoing nephrectomy using immunohistochemistry. Transcriptomic analysis was performed to assess immune-related gene signature and gene expressions.

Results

FGFR1 expression was elevated in over 80% of ccRCC samples and was significantly associated with increased CD163-positive TAM infiltration. FGFR1 expression was also negatively correlated with the IMmotion150 Teff gene signature and the expression of interferon-γ signaling targeted genes such as IFNG , GZMB , and CD274 , suggesting an immunosuppressive phenotype. In contrast, FGFR2 and FGFR4 expression were less prevalent, and FGFR3 expression was not detected.

Conclusions

This study provides the first comprehensive evaluation of FGFR1–4 expression in ccRCC and suggests that FGFR1 expression may contribute to the immunosuppressive tumor microenvironment by recruiting TAM. These findings indicate that FGFR1 could serve as a potential biomarker for therapeutic strategies and highlight the need for further research to explore FGFR-targeted therapies in ccRCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentCarcinoma, Renal CellKidney NeoplasmsReceptors, Fibroblast Growth FactorReceptor, Fibroblast Growth Factor, Type 1Fibroblast Growth FactorsHumansSignal TransductionFemaleMaleGene Expression Regulation, NeoplasticTumor-Associated MacrophagesMiddle AgedAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenAgedReceptors, Cell SurfaceReceptor, Fibroblast Growth Factor, Type 4

Substanzen

Receptors, Fibroblast Growth FactorReceptor, Fibroblast Growth Factor, Type 1FGFR1 protein, humanAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenFGFR4 protein, humanReceptors, Cell SurfaceFibroblast Growth FactorsReceptor, Fibroblast Growth Factor, Type 4

Autor:innen und Institutionen

  • Department of Urology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
  • Medical Headquarters, Eisai Co., Ltd., Tokyo, Japan.
  • Department of Pathology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
  • Division of Multi-omics Research, Yamagata University Well-Being Institute, Yamagata, Japan.
  • Deep Human Biology Learning, Eisai Co., Ltd., Tokyo, Japan.

ORCID-Profile: Takafumi Narisawa, Rintaro Ohe, Chizuru Kobayashi, Mitsuru Futakuchi

Förderung

  • Eisai Co., Ltd.

Zitieren

APA

Narisawa, T., Naito, S., Mitsuda, Y., Ohe, R., Sato, H., Kobayashi, C., Miyano, Y., Ito, H., Futakuchi, M., & Tsuchiya, N. (2026). Exploring the crosstalk between the FGF/FGFR pathway and tumor microenvironment in clear cell renal cell carcinoma. PLOS One. https://doi.org/10.1371/journal.pone.0339888

Vancouver

Narisawa T, Naito S, Mitsuda Y, Ohe R, Sato H, Kobayashi C, et al. Exploring the crosstalk between the FGF/FGFR pathway and tumor microenvironment in clear cell renal cell carcinoma. PLOS One. 2026. doi:10.1371/journal.pone.0339888

BibTeX
@article{Narisawa2026,
  author = {Narisawa, Takafumi and Naito, Sei and Mitsuda, Yoshihide and Ohe, Rintaro and Sato, Hidenori and Kobayashi, Chizuru and Miyano, Yuki and Ito, Hiromi and Futakuchi, Mitsuru and Tsuchiya, Norihiko},
  title = {Exploring the crosstalk between the FGF/FGFR pathway and tumor microenvironment in clear cell renal cell carcinoma},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0339888}
}
Kostenlos starten →